Therapeutic Protein Market by Application - Global Industry Analysis & Forecast to 2025

Published On : September 2019 Pages : 172 Category: Pharmaceuticals Report Code : HC095693

Therapeutic Protein Market by Application (Metabolic Disorders, Cancer, Hormonal Disorders, Others) - Global Industry Analysis & Forecast to 2025

Industry Outlook and Trend Analysis

The therapeutic protein market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Therapeutic proteins are the proteins that are built in the lab for pharmaceutical use, including noncovalent binders, proteins that influence covalent bonds which are practically all enzymes, and albumin. Protein therapeutics allows an individualized treatment approach by supporting an explicitly focused on remedial procedure by remunerating the lack of a fundamental protein. Advantage of the protein therapeutics include highly specific and complex set of functions, faster clinical development and FDA approval and Effective replacement treatment without the need for gene therapy.

Drivers and Restraints

Rise in prevalence of chronic diseases coupled with increasing adoption of therapeutic protein that in turn drives the growth of therapeutic protein market. Rapid development of plasma-derived therapies propels the growth of therapeutic protein market. Increasing awareness regarding therapeutic protein fuels the growth of therapeutic protein market. However, government regulations regarding therapeutic protein may hamper the growth of therapeutic protein market. Growing adoption of protein therapeutics for novel indications provides beneficial opportunities for the therapeutic protein market.

Regional Insights

Among the geographies, North America is expected to dominate the therapeutic protein market. Increasing adoption of therapeutic protein in the region contribute to the growth of therapeutic protein market.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Abbott Laboratories
  • Sanofi
  • Johnson & Johnson
  • Amgen Inc.
  • Pfizer Inc.
  • Baxter International Inc.
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • F. Hoffmann-La Roche Ltd.

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Therapeutic Protein Market, By Application, Estimates and Forecast, 2014-2025 ($Million)

o    Metabolic Disorders

o    Cancer

o    Hormonal Disorders

o    Others

·         Therapeutic Protein Market, By Key Players, Estimates and Forecast, 2014-2025 ($Million)

o    Abbott Laboratories

o    Sanofi

o    Johnson & Johnson

o    Amgen Inc.

o    Pfizer Inc.

o    Baxter International Inc.

o    Novo Nordisk A/S

o    Eli Lilly and Company

o    Merck & Co., Inc.

o    F. Hoffmann-La Roche Ltd.

·         Therapeutic Protein Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

o    North America

§  North America Therapeutic Protein Market, By Country

o    U.S. Therapeutic Protein Market

o    Canada Therapeutic Protein Market

o    Mexico Therapeutic Protein Market

o    Europe

§  Europe Therapeutic Protein Market, By Country

o    Germany Therapeutic Protein Market

o    UK Therapeutic Protein Market

o    France Therapeutic Protein Market

o    Russia Therapeutic Protein Market

o    Italy Therapeutic Protein Market

o    Rest of Europe Therapeutic Protein Market

o    Asia-Pacific

§  Asia-Pacific Therapeutic Protein Market, By Country

o    China Therapeutic Protein Market

o    Japan Therapeutic Protein Market

o    South Korea Therapeutic Protein Market

o    India Therapeutic Protein Market

o    Southeast Asia Therapeutic Protein Market

o    Rest of Asia-Pacific Therapeutic Protein Market

o    South America

§  South America Therapeutic Protein Market

o    Brazil Therapeutic Protein Market

o    Argentina Therapeutic Protein Market

o    Columbia Therapeutic Protein Market

o    Rest of South America Therapeutic Protein Market

o    Middle East and Africa

§  Middle East and Africa Therapeutic Protein Market

o    Saudi Arabia Therapeutic Protein Market

o    UAE Therapeutic Protein Market

o    Egypt Therapeutic Protein Market

o    Nigeria Therapeutic Protein Market

o    South Africa Therapeutic Protein Market

o    Rest of MEA Therapeutic Protein Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Therapeutic Protein Market, By Application

5.1.     Introduction

5.2.     Global Therapeutic Protein Revenue and Market Share by Application  (2014-2018)

5.2.1.  Global Therapeutic Protein Revenue and Revenue Share by Application  (2014-2018)

5.3.     Metabolic Disorders

5.3.1.  Global Metabolic Disorders Revenue and Growth Rate (2014-2018)

5.4.     Cancer

5.4.1.  Global Cancer Revenue and Growth Rate (2014-2018)

5.5.     Hormonal Disorders

5.5.1.  Global Hormonal Disorders Revenue and Growth Rate (2014-2018)

5.6.     Others

5.6.1.  Global Others Revenue and Growth Rate (2014-2018)

6.       Therapeutic Protein Market, By Region

6.1.     Introduction

6.2.     Global Therapeutic Protein Revenue and Market Share by Regions

6.2.1.  Global Therapeutic Protein Revenue by Regions (2014-2018)

6.3.     North America Therapeutic Protein by Countries

6.3.1.  North America Therapeutic Protein Revenue and Growth Rate (2014-2018)

6.3.2.  North America Therapeutic Protein Revenue (Million USD) by Countries (2014-2018)

6.3.3.  United States

6.3.3.1.  United States Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.3.4.  Canada

6.3.4.1.  Canada Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.3.5.  Mexico

6.3.5.1.  Mexico Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.     Europe Therapeutic Protein by Countries

6.4.1.  Europe Therapeutic Protein Revenue and Growth Rate (2014-2018)

6.4.2.  Europe Therapeutic Protein Revenue (Million USD) by Countries (2014-2018)

6.4.3.  Germany

6.4.3.1.  Germany Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.4.  France

6.4.4.1.  France Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.5.  UK

6.4.5.1.  UK Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.6.  Russia

6.4.6.1.  Russia Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.7.  Italy

6.4.7.1.  Italy Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.4.8.  Rest of Europe

6.4.8.1.  Rest of Europe Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.     Asia-Pacific Therapeutic Protein by Countries

6.5.1.  Asia-Pacific Therapeutic Protein Revenue and Growth Rate (2014-2018)

6.5.2.  Asia-Pacific Therapeutic Protein Revenue (Million USD) by Countries (2014-2018)

6.5.3.  China

6.5.3.1.  China Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.4.  Japan

6.5.4.1.  Japan Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.5.  Korea

6.5.5.1.  Korea Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.6.  India

6.5.6.1.  India Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.7.  Southeast Asia

6.5.7.1.  Southeast Asia Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.5.8.  Rest of Asia-Pacific

6.5.8.1.  Rest of Asia-Pacific Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.     South America Therapeutic Protein by Countries

6.6.1.  South America Therapeutic Protein Revenue and Growth Rate (2014-2018)

6.6.2.  South America Therapeutic Protein Revenue (Million USD) by Countries (2014-2018)

6.6.3.  Brazil

6.6.3.1.  Brazil Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.4.  Argentina

6.6.4.1.  Argentina Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.5.  Columbia

6.6.5.1.  Columbia Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.6.6.  Rest of South America

6.6.6.1.  Rest of South America Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.     Middle East and Africa Therapeutic Protein by Countries

6.7.1.  Middle East and Africa Therapeutic Protein Revenue and Growth Rate (2014-2018)

6.7.2.  Middle East and Africa Therapeutic Protein Revenue (Million USD) by Countries (2014-2018)

6.7.3.  Saudi Arabia

6.7.3.1.  Saudi Arabia Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.4.  United Arab Emirates

6.7.4.1.  United Arab Emirates Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.5.  Egypt

6.7.5.1.  Egypt Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.6.  Nigeria

6.7.6.1.  Nigeria Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.7.  South Africa

6.7.7.1.  South Africa Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.8.  Turkey

6.7.8.1.  Turkey Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

6.7.9.  Rest of Middle East and Africa

6.7.9.1.  Rest of Middle East and Africa Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)

7.       Company Profiles

7.1.     Abbott Laboratories

7.1.1.  Business Overview

7.1.2.   Service Portfolio

7.1.3.  Strategic Developments

7.1.4.  Financial Overview

7.2.     Sanofi

7.2.1.  Business Overview

7.2.2.   Service Portfolio

7.2.3.  Strategic Developments

7.2.4.  Financial Overview

7.3.     Johnson & Johnson

7.3.1.  Business Overview

7.3.2.   Service Portfolio

7.3.3.  Strategic Developments

7.3.4.  Financial Overview

7.4.     Amgen Inc.

7.4.1.  Business Overview

7.4.2.   Service Portfolio

7.4.3.  Strategic Developments

7.4.4.  Financial Overview

7.5.     Pfizer Inc.

7.5.1.  Business Overview

7.5.2.   Service Portfolio

7.5.3.  Strategic Developments

7.5.4.  Financial Overview

7.6.     Baxter International Inc.

7.6.1.  Business Overview

7.6.2.   Service Portfolio

7.6.3.  Strategic Developments

7.6.4.  Financial Overview

7.7.     Novo Nordisk A/S

7.7.1.  Business Overview

7.7.2.   Service Portfolio

7.7.3.  Strategic Developments

7.7.4.  Financial Overview

7.8.     Eli Lilly and Company

7.8.1.  Business Overview

7.8.2.   Service Portfolio

7.8.3.  Strategic Developments

7.8.4.  Financial Overview

7.9.     Merck & Co., Inc.

7.9.1.  Business Overview

7.9.2.   Service Portfolio

7.9.3.  Strategic Developments

7.9.4.  Financial Overview

7.10. F. Hoffmann-La Roche Ltd.

7.10.1.      Business Overview

7.10.2.       Service Portfolio

7.10.3.      Strategic Developments

7.10.4.      Financial Overview

8.       Therapeutic Protein Market Forecast (2018-2025)

8.1.     Global Therapeutic Protein Revenue (Millions USD) and Growth Rate (2018-2025)

8.2.     Therapeutic Protein Market Forecast by Regions (2018-2025)

8.2.1.  North America Therapeutic Protein Market Forecast (2018-2025)

8.2.1.1.  United States Therapeutic Protein Market Forecast (2018-2025)

8.2.1.2.  Canada Therapeutic Protein Market Forecast (2018-2025)

8.2.1.3.  Mexico Therapeutic Protein Market Forecast (2018-2025)

8.2.2.  Europe Therapeutic Protein Market Forecast (2018-2025)

8.2.2.1.  Germany Therapeutic Protein Market Forecast (2018-2025)

8.2.2.2.  France Therapeutic Protein Market Forecast (2018-2025)

8.2.2.3.  UK Therapeutic Protein Market Forecast (2018-2025)

8.2.2.4.  Russia Therapeutic Protein Market Forecast (2018-2025)

8.2.2.5.  Italy Therapeutic Protein Market Forecast (2018-2025)

8.2.2.6.  Rest of Europe Therapeutic Protein Market Forecast (2018-2025)

8.2.3.  Asia-Pacific Therapeutic Protein Market Forecast (2018-2025)

8.2.3.1.  China Therapeutic Protein Market Forecast (2018-2025)

8.2.3.2.  Japan Therapeutic Protein Market Forecast (2018-2025)

8.2.3.3.  Korea Therapeutic Protein Market Forecast (2018-2025)

8.2.3.4.  India Therapeutic Protein Market Forecast (2018-2025)

8.2.3.5.  Southeast Asia Therapeutic Protein Market Forecast (2018-2025)

8.2.3.6.  Rest of Asia-Pacific Therapeutic Protein Market Forecast (2018-2025)

8.2.4.  South America Therapeutic Protein Market Forecast (2018-2025)

8.2.4.1.  Brazil Therapeutic Protein Market Forecast (2018-2025)

8.2.4.2.  Argentina Therapeutic Protein Market Forecast (2018-2025)

8.2.4.3.  Columbia Therapeutic Protein Market Forecast (2018-2025)

8.2.4.4.  Rest of South America Therapeutic Protein Market Forecast (2018-2025)

8.2.5.  Middle East and Africa Therapeutic Protein Market Forecast (2018-2025)

8.2.5.1.  Saudi Arabia Therapeutic Protein Market Forecast (2018-2025)

8.2.5.2.  United Arab Emirates Therapeutic Protein Market Forecast (2018-2025)

8.2.5.3.  Egypt Therapeutic Protein Market Forecast (2018-2025)

8.2.5.4.  Nigeria Therapeutic Protein Market Forecast (2018-2025)

8.2.5.5.  South Africa Therapeutic Protein Market Forecast (2018-2025)

8.2.5.6.  Turkey Therapeutic Protein Market Forecast (2018-2025)

8.2.5.7.  Rest of Middle East and Africa Therapeutic Protein Market Forecast (2018-2025)

8.3.     Therapeutic Protein Market Forecast by Application  (2018-2025)

8.3.1.  Therapeutic Protein Forecast by Application  (2018-2025)

8.3.2.  Therapeutic Protein Market Share Forecast by Application  (2018-2025)


List of Tables

List of Tables and Figures:

Figure United States Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Therapeutic Protein Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Therapeutic Protein Revenue and Revenue Share by Application (2014-2018)
Figure Global Metabolic Disorders Revenue and Growth Rate (2014-2018)
Figure Global Cancer Revenue and Growth Rate (2014-2018)
Figure Global Hormonal Disorders Revenue and Growth Rate (2014-2018)
Figure Global Others Revenue and Growth Rate (2014-2018)
Table Global Therapeutic Protein Revenue by Regions (2014-2018)
Figure North America Therapeutic Protein Growth Rate (2014-2018)
Figure North America Therapeutic Protein Revenue and Growth Rate (2014-2018)
Figure North America Therapeutic Protein by Countries (2014-2018)
Figure North America Therapeutic Protein Revenue (Million USD) by Countries (2014-2018)
Figure United States Therapeutic Protein Growth Rate (2014-2018)
Figure United States Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Therapeutic Protein Growth Rate (2014-2018)
Figure Canada Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Therapeutic Protein Growth Rate (2014-2018)
Figure Mexico Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Therapeutic Protein Growth Rate (2014-2018)
Figure Europe Therapeutic Protein Revenue and Growth Rate (2014-2018)
Figure Europe Therapeutic Protein by Countries (2014-2018)
Figure Europe Therapeutic Protein Revenue (Million USD) by Countries (2014-2018)
Figure Germany Therapeutic Protein Growth Rate (2014-2018)
Figure Germany Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Therapeutic Protein Growth Rate (2014-2018)
Figure France Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Therapeutic Protein Growth Rate (2014-2018)
Figure UK Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Therapeutic Protein Growth Rate (2014-2018)
Figure Russia Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Therapeutic Protein Growth Rate (2014-2018)
Figure Italy Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Therapeutic Protein Growth Rate (2014-2018)
Figure Rest of Europe Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Therapeutic Protein Growth Rate (2014-2018)
Figure Asia-Pacific Therapeutic Protein Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Therapeutic Protein by Countries (2014-2018)
Figure Asia-Pacific Therapeutic Protein Revenue (Million USD) by Countries (2014-2018)
Figure China Therapeutic Protein Growth Rate (2014-2018)
Figure China Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Therapeutic Protein Growth Rate (2014-2018)
Figure Japan Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Therapeutic Protein Growth Rate (2014-2018)
Figure Korea Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Therapeutic Protein Growth Rate (2014-2018)
Figure India Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Therapeutic Protein Growth Rate (2014-2018)
Figure Southeast Asia Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Therapeutic Protein Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Therapeutic Protein Growth Rate (2014-2018)
Figure South America Therapeutic Protein Revenue and Growth Rate (2014-2018)
Figure South America Therapeutic Protein by Countries (2014-2018)
Figure South America Therapeutic Protein Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Therapeutic Protein Growth Rate (2014-2018)
Figure Brazil Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Therapeutic Protein Growth Rate (2014-2018)
Figure Argentina Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Therapeutic Protein Growth Rate (2014-2018)
Figure Columbia Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Therapeutic Protein Growth Rate (2014-2018)
Figure Rest of South America Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Therapeutic Protein Growth Rate (2014-2018)
Figure Middle East and Africa Therapeutic Protein Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Therapeutic Protein by Countries (2014-2018)
Figure Middle East and Africa Therapeutic Protein Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Therapeutic Protein Growth Rate (2014-2018)
Figure Saudi Arabia Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Therapeutic Protein Growth Rate (2014-2018)
Figure United Arab Emirates Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Therapeutic Protein Growth Rate (2014-2018)
Figure Egypt Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Therapeutic Protein Growth Rate (2014-2018)
Figure Nigeria Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Therapeutic Protein Growth Rate (2014-2018)
Figure South Africa Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Therapeutic Protein Growth Rate (2014-2018)
Figure Turkey Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Therapeutic Protein Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Therapeutic Protein Revenue (Millions USD) and Growth Rate (2014-2018)
Table Abbott Laboratories Therapeutic Protein Financial Overview
Table Sanofi Therapeutic Protein Financial Overview
Table Johnson & Johnson Therapeutic Protein Financial Overview
Table Amgen Inc. Therapeutic Protein Financial Overview
Table Pfizer Inc. Therapeutic Protein Financial Overview
Table Baxter International Inc. Therapeutic Protein Financial Overview
Table Novo Nordisk A/S Therapeutic Protein Financial Overview
Table Eli Lilly and Company Therapeutic Protein Financial Overview
Table Merck & Co., Inc. Therapeutic Protein Financial Overview
Table F. Hoffmann-La Roche Ltd. Therapeutic Protein Financial Overview
Figure Global Therapeutic Protein Revenue (Millions USD) and Growth Rate (2018-2025)
Table Therapeutic Protein Market Forecast by Regions (2018-2025)
Figure North America Therapeutic Protein Market Forecast (2018-2025)
Figure United States Therapeutic Protein Market Forecast (2018-2025)
Figure Canada Therapeutic Protein Market Forecast (2018-2025)
Figure Mexico Therapeutic Protein Market Forecast (2018-2025)
Figure Europe Therapeutic Protein Market Forecast (2018-2025)
Figure Germany Therapeutic Protein Market Forecast (2018-2025)
Figure France Therapeutic Protein Market Forecast (2018-2025)
Figure UK Therapeutic Protein Market Forecast (2018-2025)
Figure Russia Therapeutic Protein Market Forecast (2018-2025)
Figure Italy Therapeutic Protein Market Forecast (2018-2025)
Figure Rest of Europe Therapeutic Protein Market Forecast (2018-2025)
Figure Asia-Pacific Therapeutic Protein Market Forecast (2018-2025)
Figure China Therapeutic Protein Market Forecast (2018-2025)
Figure Japan Therapeutic Protein Market Forecast (2018-2025)
Figure Korea Therapeutic Protein Market Forecast (2018-2025)
Figure India Therapeutic Protein Market Forecast (2018-2025)
Figure Southeast Asia Therapeutic Protein Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Therapeutic Protein Market Forecast (2018-2025)
Figure South America Therapeutic Protein Market Forecast (2018-2025)
Figure Brazil Therapeutic Protein Market Forecast (2018-2025)
Figure Argentina Therapeutic Protein Market Forecast (2018-2025)
Figure Columbia Therapeutic Protein Market Forecast (2018-2025)
Figure Rest of South America Therapeutic Protein Market Forecast (2018-2025)
Figure Middle East and Africa Therapeutic Protein Market Forecast (2018-2025)
Figure Saudi Arabia Therapeutic Protein Market Forecast (2018-2025)
Figure United Arab Emirates Therapeutic Protein Market Forecast (2018-2025)
Figure Egypt Therapeutic Protein Market Forecast (2018-2025)
Figure Nigeria Therapeutic Protein Market Forecast (2018-2025)
Figure South Africa Therapeutic Protein Market Forecast (2018-2025)
Figure Turkey Therapeutic Protein Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Therapeutic Protein Market Forecast (2018-2025)
Figure Global Therapeutic Protein Forecast by Application (2018-2025)
Figure Global Therapeutic Protein Market Share Forecast by Application (2018-2025)
Figure Global Therapeutic Protein Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*